Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
112.26
+0.11 (0.10%)
At close: Mar 28, 2025, 4:00 PM
109.35
-2.91 (-2.59%)
After-hours: Mar 28, 2025, 6:21 PM EDT
Zimmer Biomet Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 7,679 | 7,394 | 6,940 | 6,827 | 6,128 | Upgrade
|
| Revenue Growth (YoY) | 3.85% | 6.55% | 1.65% | 11.42% | -23.23% | Upgrade
|
| Cost of Revenue | 2,180 | 2,076 | 2,020 | 1,960 | 1,824 | Upgrade
|
| Gross Profit | 5,499 | 5,319 | 4,920 | 4,867 | 4,303 | Upgrade
|
| Selling, General & Admin | 2,876 | 2,793 | 2,668 | 2,626 | 2,524 | Upgrade
|
| Research & Development | 437.4 | 458.7 | 406 | 435.8 | 322.8 | Upgrade
|
| Other Operating Expenses | - | - | 33.8 | 52.8 | 50.9 | Upgrade
|
| Operating Expenses | 3,905 | 3,813 | 3,634 | 3,645 | 3,410 | Upgrade
|
| Operating Income | 1,594 | 1,505 | 1,286 | 1,222 | 893 | Upgrade
|
| Interest Expense | -218 | -201.2 | -164.8 | -208.4 | -212.1 | Upgrade
|
| Currency Exchange Gain (Loss) | -15.6 | -17.2 | -19.7 | -5.5 | -12.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 3 | -0.3 | -0.5 | 1.7 | 13.7 | Upgrade
|
| EBT Excluding Unusual Items | 1,363 | 1,287 | 1,101 | 1,010 | 682.4 | Upgrade
|
| Merger & Restructuring Charges | -247 | -181.8 | -203 | -125.7 | -107.2 | Upgrade
|
| Impairment of Goodwill | - | - | -289.8 | - | -470 | Upgrade
|
| Gain (Loss) on Sale of Investments | -42.1 | -16 | -136 | - | - | Upgrade
|
| Legal Settlements | -30.5 | -21.6 | -65.9 | -201 | -166 | Upgrade
|
| Other Unusual Items | -7.1 | - | - | -168.2 | -11.4 | Upgrade
|
| Pretax Income | 1,037 | 1,067 | 403.5 | 499 | -105.2 | Upgrade
|
| Income Tax Expense | 131.4 | 42.2 | 112.3 | 53.5 | -96 | Upgrade
|
| Earnings From Continuing Operations | 905.3 | 1,025 | 291.2 | 445.5 | -9.2 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -58.8 | -43.4 | -128.2 | Upgrade
|
| Net Income to Company | 905.3 | 1,025 | 232.4 | 402.1 | -137.4 | Upgrade
|
| Minority Interest in Earnings | -1.5 | -1.1 | -1 | -0.5 | -1.5 | Upgrade
|
| Net Income | 903.8 | 1,024 | 231.4 | 401.6 | -138.9 | Upgrade
|
| Net Income to Common | 903.8 | 1,024 | 231.4 | 401.6 | -138.9 | Upgrade
|
| Net Income Growth | -11.74% | 342.52% | -42.38% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 203 | 209 | 210 | 209 | 207 | Upgrade
|
| Shares Outstanding (Diluted) | 204 | 210 | 210 | 210 | 207 | Upgrade
|
| Shares Change (YoY) | -2.77% | -0.29% | -0.05% | 1.64% | 0.14% | Upgrade
|
| EPS (Basic) | 4.45 | 4.91 | 1.10 | 1.93 | -0.67 | Upgrade
|
| EPS (Diluted) | 4.43 | 4.88 | 1.10 | 1.91 | -0.67 | Upgrade
|
| EPS Growth | -9.22% | 343.48% | -42.50% | - | - | Upgrade
|
| Free Cash Flow | 1,055 | 978.8 | 838.5 | 1,082 | 833.6 | Upgrade
|
| Free Cash Flow Per Share | 5.18 | 4.67 | 3.99 | 5.14 | 4.03 | Upgrade
|
| Dividend Per Share | 0.960 | 0.960 | 0.960 | 0.960 | 0.960 | Upgrade
|
| Gross Margin | 71.61% | 71.93% | 70.90% | 71.29% | 70.23% | Upgrade
|
| Operating Margin | 20.76% | 20.36% | 18.53% | 17.90% | 14.57% | Upgrade
|
| Profit Margin | 11.77% | 13.85% | 3.33% | 5.88% | -2.27% | Upgrade
|
| Free Cash Flow Margin | 13.74% | 13.24% | 12.08% | 15.85% | 13.60% | Upgrade
|
| EBITDA | 2,590 | 2,457 | 2,213 | 2,160 | 1,791 | Upgrade
|
| EBITDA Margin | 33.73% | 33.23% | 31.88% | 31.64% | 29.23% | Upgrade
|
| D&A For EBITDA | 996.3 | 951.7 | 926.4 | 937.7 | 898.4 | Upgrade
|
| EBIT | 1,594 | 1,505 | 1,286 | 1,222 | 893 | Upgrade
|
| EBIT Margin | 20.76% | 20.36% | 18.53% | 17.90% | 14.57% | Upgrade
|
| Effective Tax Rate | 12.68% | 3.95% | 27.83% | 10.72% | - | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.